Leaflet KANAMICINA PANPHARMA 1g powder for injection / infusion solution


Indicated for: bacterial infections

Substance: kanamycin (aminoglycoside antibiotic)

ATC: J01GB04 (Antiinfectives for systemic use | Aminoglycoside antibacterials | Other aminoglycosides)

Kanamycin is an aminoglycoside antibiotic used to treat severe bacterial infections such as tuberculosis or abdominal infections. It works by inhibiting bacterial protein synthesis, thereby killing susceptible bacteria.

The medication is usually administered via intramuscular or intravenous injection under medical supervision.

Side effects may include kidney function impairment, hearing loss, or allergic reactions. Long-term use requires careful monitoring to prevent toxicity.

Patients should inform their doctor about any other medications they are taking and avoid concurrent use with other ototoxic or nephrotoxic drugs. Pregnant or breastfeeding women should consult a specialist before use.

General data about KANAMICINA PANPHARMA 1g

  • Substance: kanamycin
  • Date of last drug list: 01-03-2022
  • Commercial code: W61665001
  • Concentration: 1g
  • Pharmaceutical form: powder for injection / infusion solution
  • Quantity: 50
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: PANPHARMA - FRANTA
  • Holder: PANPHARMA - FRANTA
  • Number: 13176/2020/01
  • Shelf life: 3 years-after packing for marketing;after reconstitution-it is used immediately

Concentrations available for kanamycin

  • 1%
  • 10mg/g
  • 1g

Combinations with other substances